Propofol-Fentanyl-Dexmedetomidine and Propofol-Fentanyl-Sevoflurane Anesthesia for Major Spine Surgery Under Somato Sensory- and Motor- Evoked Potential Monitoring
Launched by AIN SHAMS UNIVERSITY · Jan 6, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the effects of two different anesthesia methods on patients undergoing major spine surgery. Specifically, it is comparing a combination of medications called propofol, fentanyl, and dexmedetomidine with another combination that includes propofol, fentanyl, and sevoflurane. The goal is to see how adding dexmedetomidine affects certain signals in the nervous system that doctors monitor during surgery to ensure everything is functioning well.
To be eligible for this trial, participants need to be between 21 and 45 years old and in good health (classified as ASA physical status I or II). This means they should not have serious health issues that could complicate the surgery or anesthesia. Participants can expect to be closely monitored during their surgery, and their responses to the anesthesia will be carefully studied. It’s important to note that individuals with allergies to any of the study medications or certain medical conditions, like severe respiratory diseases or specific nerve disorders, will not be able to participate. If you think you might be a good candidate and are interested in learning more, please discuss it with your doctor.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age from 21-45 years.
- • Both sexes.
- • American Society of Anesthesiology (ASA) physical status I and II.
- • Undergoing major spine surgery
- Exclusion Criteria:
- • Refusal of procedure or participation in the study by patients.
- • Patients with known history of allergy to one of study drugs
- • Patients with nerve conduction pathway injury.
- • Severe circulatory or respiratory disease.
- • Cognitive or psychiatric illness that leads to inability to cooperate, speak or provide informed consent
- • Patients with history of Myasthenia gravis, epilepsy , history of pacemaker implantation .
- • Patients who need to be awakened during the procedure.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported